ZMYND8 and neoplasm: To exclude a role of ZMYND8–mediated immune response in tumor initiation, we compared the initiation frequency of SC and ZMYND8-KO 4T1 tumors in both immunocompromised NSG mice and immunocompetent BALB/c mice using limiting dilution assay.